Work

Safety and efficacy of everolimus as a rescue therapy in autoimmune hepatitis: 12-months follow-up data

Year: 2026

Type: conference-paper

Abstract: Background and objective: In autoimmune hepatitis (AIH), some patients fail to respond to first-line immunosuppression or develop treatment-related malignancies requiring alternative treatments. Rapamycin (mTOR) inhibitors may represent an alternative treatment strategy; however, long-term follow-up [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/26vzmnrw129

Authors: Seltsam, F., Daniel, M., Krawczyk, M., Schmidt, H. H., Veltkamp, C.

Institution: Essen University Hospital

Language: English

Topic: Liver Diseases and Immunity

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7165134139

FWCI:

Cites:

Cited by:

Related to: